Biocryst Pharmaceuticals (BCRX)

Add to Watchlists Create an Alert
13.50 +0.29  +2.20% NASDAQ Aug 29, 8:00PM BATS Real time Currency in USD
View Full Chart
BCRX Price Chart
View All Events

BCRX Events

Date Type Description
08/05/2014 11:00 EDT Misc Q2 2014 Biocryst Pharmaceuticals Earnings Call
08/05/2014 Earnings Q2 2014 Biocryst Pharmaceuticals Earnings Results
05/08/2014 Misc Q1 2014 Biocryst Pharmaceuticals Earnings Call
05/02/2014 15:00 EDT Misc Biocryst Announces Nature Publication Demonstrating Efficacy of Bcx4430 in a Non-human Primate Model of Filovirus Infection
05/02/2014 Misc Annual General Meeting for Biocryst Pharmaceuticals Inc
03/03/2014 Earnings Q1 2014 Biocryst Pharmaceuticals Earnings Results
02/26/2014 11:00 EDT Misc Q4 2013 Biocryst Pharmaceuticals Earnings Call
02/26/2014 Earnings Q4 2013 Biocryst Pharmaceuticals Earnings Results
11/05/2013 11:00 EDT Misc Biocryst Third Quarter 2013 Conference Call
11/05/2013 Earnings Biocryst Pharmaceuticals 3Q13 Reporting
View All Performance Charts

BCRX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Biocryst Pharmaceuticals is up 106.7% over the last year vs S&P 500 Total Return up 24.86%, NewLink Genetics up 55.81%, and Sarepta Therapeutics down 33.21%.

Get Quote for

PDF Report for BCRX

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download BCRX Pro Report PDF

Portfolio Strategies Featuring BCRX

Did Biocryst Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

BCRX Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website:
  • IR Website:
  • HQ Country: United States
  • HQ State/Province: North Carolina
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: September 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: June 30, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Biological Product (Except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Biocryst Pharmaceuticals Inc. is engaged in the design, optimization and development of novel drugs that block key enzymes involved in the pathogenesis of diseases. Its drug candidates include Peramivir, BCX4161, Forodesine and Ulodesine, among others.

BCRX Excel Add-In Codes

  • Name: =YCI("BCRX","name")
  • Description: =YCI("BCRX","description")
  • Sector: =YCI("BCRX","sector")
  • Industry: =YCI("BCRX","industry")
  • Est. Current Fiscal Year End: =YCI("BCRX","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.


Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start your {{}} Membership


{{ ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{}} Member? Sign in here.